The IP practice at Clayton Utz has suffered the departures of Peter Knight and Anna Sharpe, who both retired from the partnership in January 2009, but remains one of the best around. Providing both front-end and back-end advice, the firm specialises ...
[more]
The IP practice at Clayton Utz has suffered the departures of Peter Knight and Anna Sharpe, who both retired from the partnership in January 2009, but remains one of the best around. Providing both front-end and back-end advice, the firm specialises in all aspects of IP law, passing off and Trade Practices Act claims and related commercial disputes, and now houses a dedicated trade marks group.
Key clients of the practice include Eli Lilly & Company, Astrazeneca, Weatherford International, Free TV Australia and Racing Victoria.
The highlight of its patent litigation work is undoubtedly its work for Eli Lilly concerning patent infringement and revocation allegations for the company’s gemcitabine hydrochloride molecule. This forms the basis of its successful anti-cancer treatment GEMZAR, and the case deals directly with the complex interplay of patent rights, product registration and PBS (Australia’s Pharmaceutical Benefits Scheme) listing procedures.
A significant copyright tribunal dispute is the firm’s instruction by Free TV Australia in proceedings commenced by Phonographic Performance Co of Australia, which represents the interests of record labels and Australian recording artists. The proceedings relate to a licensing scheme for the television broadcast of commercial sound recordings in Australia, and this will be the first determination of such a scheme by the Copyright Tribunal.
Practice head John Collins is advising on the Eli Lilly case. Other star performers include John Fairbairn and Kate Marshall.
[hide]